Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups.
暂无分享,去创建一个
J. Blay | J. Coindre | P. Bruzzi | D. Merlo | A. D. Dei Tos | P. Casali | A. Marrari | A. Gronchi | C. Morosi | P. Picci | S. Stacchiotti | L. Braglia | G. Bianchi | S. Bagué | V. Ferraresi | G. Grignani | I. Lugowska | D. Donati | A. Brunello | E. Palmerini | E. Palassini | V. Quagliuolo | V. Fontana | J. Martín Broto | R. Díaz Beveridge | A. López Pousa | E. Marchesi | O. Tendero | Oscar Tendero | J. Martin Broto
[1] J. Blay,et al. Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups , 2019, EClinicalMedicine.
[2] S. Litière,et al. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial. , 2019, European journal of cancer.
[3] J. Wunder,et al. Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres. , 2018, European journal of cancer.
[4] S. Sleijfer,et al. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] J. Blay,et al. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. , 2017, The Lancet. Oncology.
[6] A. Llombart‐Bosch,et al. Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[7] L. Mariani,et al. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis. , 2016, The Lancet. Oncology.
[8] S. Steinberg,et al. SARC006: Phase II trial of chemotherapy in sporadic and neurofibromatosis type 1 (NF1)-associated high-grade malignant peripheral nerve sheath tumors (MPNSTs). , 2013 .
[9] A. D. Dei Tos,et al. Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[10] C. Fletcher,et al. WHO classification of tumours of soft tissue and bone , 2013 .
[11] A. Llombart‐Bosch,et al. Tumor response assessment by modified Choi criteria in localized high‐risk soft tissue sarcoma treated with chemotherapy , 2012, Cancer.
[12] J. Verweij,et al. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. , 2012, The Lancet. Oncology.
[13] J. Maurel,et al. Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] V. Torri,et al. High-grade soft-tissue sarcomas: tumor response assessment--pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria. , 2009, Radiology.
[15] L. Schwartz,et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.
[16] L. Qin,et al. A Synovial Sarcoma-Specific Preoperative Nomogram Supports a Survival Benefit to Ifosfamide-Based Chemotherapy and Improves Risk Stratification for Patients , 2008, Clinical Cancer Research.
[17] F. Farrokhyar,et al. A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma , 2008, Cancer.
[18] Robin L. Jones,et al. Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study. , 2007, The Lancet. Oncology.
[19] Haesun Choi,et al. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] P. Thall,et al. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] Stuart J Pocock,et al. Current controversies in data monitoring for clinical trials , 2006, Clinical trials.
[22] M. Berretta,et al. Ifosfamide in the Adjuvant Therapy of Soft Tissue Sarcomas , 2003, Oncology.
[23] M Bonetti,et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] R. Sylvester,et al. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data , 1997 .
[25] J. Coindre,et al. Soft‐tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system , 1984, International journal of cancer.
[26] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[27] D.,et al. Regression Models and Life-Tables , 2022 .